Study 7 of 15Bofanglutide literatureNatureTop journal2024
NK2R control of energy expenditure and feeding to treat metabolic diseases.
Not reported in abstract.
Where it sits
this study against the rest of the bofanglutide corpus5
Preclinical · this one
4
Observational
0
Open-label
2
Randomised
4
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2024
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Bofanglutide corpus
DBridging Biosynthesis and Bioavailability: Integrated Strategies for Tailoring Soybean Isoflavone Profiles.Comprehensive reviews in food science and food safety · 2026reviewDSpatiotemporal dynamics of the host-tumor metabolic interface: Implications for precision nutritional oncology.Genes & diseases · 2026reviewDOne Health implementation for rabies elimination in India by 2030: Progress, governance, challenges, and policy alignment.One health (Amsterdam, Netherlands) · 2026reviewCA Ready-to-Use Recombinant Yeast Two-Hybrid Assay for Thyroxine Detection.Biosensors · 2026 · EC50 values ranged from 350 nM to 550 nM for thyroxine.In vitroCFe(III)-(II) Mineral Transformation and Associated Organic Matter Stabilization Processes in a Tidal Marsh Soil.Environmental science & technology · 2026 · Not reported in abstract.In vitroBGlobal, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.The lancet. HIV · 2026 · 2.06 million new HIV infections globally in 2023 (1.88-2.29 million).review